Tokushima University / Educator and Researcher Directory --- Hori, Taiki

Field of Study

Subject of Study

Book / Paper

Academic Paper (Judged Full Paper):

1.	Tomoyo Hara, Hiroki Yamagami, Ryoko Uemoto, Akiko Sekine, Yousuke Kaneko, Kohsuke Miyataka, Taiki Hori, Mayuko Shimizu, Masafumi Funamoto, Takeshi Harada, Tomoyuki Yuasa, Shingen Nakamura, Itsuro Endo, Ken-ichi Matsuoka, Yutaka Kawano, Koichi Tsuneyama, Yasumasa Ikeda and Ken-ichi Aihara : Pemafibrate Ameliorates Steatotic Liver Disease Regardless of Endothelial Dysfunction in Mice., Antioxidants, 14, 7, 2025. (Summary) Endothelial dysfunction contributes to the progression of metabolic-dysfunction-associated steatotic liver disease (MASLD). Pemafibrate has been shown to ameliorate MASLD in basic and clinical studies, but it is unclear whether it is also effective in the status of endothelial dysfunction. An MASLD animal model was induced in male wild-type (WT) and endothelial nitric oxide synthase (eNOS)-deficient (eNOSKO) mice by feeding them a high-fat/cholesterol/cholate diet, and they were administered either a vehicle or pemafibrate at 0.17 mg/kg/day for 10 weeks. Although pemafibrate treatment did not change plasma lipid profiles in either WT or eNOSKO mice, pemafibrate reduced plasma AST levels in both WT and eNOSKO mice compared to the levels in the vehicle-treated mice. Histopathological analysis of the liver showed that MASLD was improved in the pemafibrate-treated groups in both WT and eNOSKO mice. Compared to vehicle treatment, pemafibrate treatment significantly reduced the expression levels of hepatic NADPH oxidase subunit genes, M1 macrophages, inflammatory-cytokine-related genes and profibrotic genes in both WT and eNOSKO mice, along with reduction in hepatic oxidative stress assessed by dihydroethidium staining and 4-hydroxynonenal protein levels. Thus, pemafibrate ameliorated MASLD with reduction in oxidative stress and inflammation even in vascular endothelial dysfunction. (Tokushima University Institutional Repository) ● Metadata: 2013384 (Link to Publication Site) ● Publication site (DOI): 10.3390/antiox14070891 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 40722995 ● Summary page in Scopus @ Elsevier: 2-s2.0-105011498553 (Tokushima University Institutional Repository: 2013384, DOI: 10.3390/antiox14070891, PubMed: 40722995, Elsevier: Scopus)
2.	Yousuke Kaneko, Yutaka Kawano, Saki Kawata, Kensuke Mori, Minae Hosoki, Taiki Hori, Kohsuke Miyataka, Seijiro Tsuji, Tomoyo Hara, Hiroki Yamagami, Toshiki Otoda, Tomoyuki Yuasa, Akio Kuroda, Takeshi Harada, Hirokazu Miki, Shingen Nakamura, Itsuro Endo, Munehide Matsuhisa, Ken-ichi Matsuoka and Ken-ichi Aihara : Mean Corpuscular Volume Is Correlated with Liver Fibrosis Defined by Noninvasive Blood Biochemical Indices in Individuals with Metabolic Disorders Aged 60 Years or Older., Journal of Clinical Medicine, 14, 13, 4680, 2025. (Summary) Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) causes progressive liver fibrosis. Although erythrocyte mean corpuscular volume (MCV) has been shown to have a positive correlation with all-cause mortality, the association between MCV and the development of MASLD has not been fully elucidated. Here, we examined the clinical significance of the association between MCV and MASLD. Methods: A cross-sectional study was carried out in 1009 Japanese individuals (including 186 individuals aged < 60 years and 823 individuals aged 60 years) with metabolic disorders. The relationships between MCV and noninvasive clinical markers of liver fibrosis, including fibrosis-4 (FIB-4) index, aspartate aminotransferase-to-platelet ratio index (APRI), and non-alcoholic fatty liver disease (NAFLD) fibrosis score (NFS), were statistically evaluated. Results: Using multiple and logistic regression analyses in overall subjects, it was found that MCV was positively and independently associated with the values of FIB-4 index, APRI, NFS, and the prevalence of liver fibrosis defined by each index. However, the associations between the MCV value and MASLD indices were found to be positive in subjects aged 60 years but not in those aged < 60 years. Conclusions: MCV might be a simple and useful biomarker for the development of MASLD in the elderly. (Tokushima University Institutional Repository) ● Metadata: 2013385 (Link to Publication Site) ● Publication site (DOI): 10.3390/jcm14134680 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 40649054 ● Search Scopus @ Elsevier (PMID): 40649054 ● Search Scopus @ Elsevier (DOI): 10.3390/jcm14134680 (Tokushima University Institutional Repository: 2013385, DOI: 10.3390/jcm14134680, PubMed: 40649054)
3.	Taiki Hori, Ken-ichi Aihara, Takeshi Watanabe, Kaori Inaba, Keisuke Inaba, Yousuke Kaneko, Saki Kawata, Keisuke Kawahito, Hiroki Kita, Kazuma Shimizu, Minae Hosoki, Kensuke Mori, Teruyoshi Kageji, Hideyuki Uraoka and Shingen Nakamura : The Respiratory Adjusted Shock Index at Admission Is a Valuable Predictor of In-Hospital Outcomes for Elderly Emergency Patients with Medical Diseases at a Japanese Community General Hospital., Journal of Clinical Medicine, 13, 16, 2024. (Summary) : The RASI is a simple indicator that can be used for predicting in-hospital outcomes in elderly emergency patients with medical diseases. Larger prospective studies based on this study are needed. (Tokushima University Institutional Repository) ● Metadata: 2012284 (Link to Publication Site) ● Publication site (DOI): 10.3390/jcm13164866 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 39201007 ● Summary page in Scopus @ Elsevier: 2-s2.0-85202690977 (Tokushima University Institutional Repository: 2012284, DOI: 10.3390/jcm13164866, PubMed: 39201007, Elsevier: Scopus)
4.	Taiki Hori, Taro Shimizu, Hidenori ANDO, Naoto Okada, Hiroki Yamagami, Saya Yasui, Minae Hosoki, Akihiro Tojima, Toshiki Otoda, Tomoyuki Yuasa, Ken-ichi Aihara, Makoto Takishita, Sumiko Yoshida, Masahiro Abe, Tatsuhiro Ishida and Shingen Nakamura : Humoral immune response against SARS-CoV-2 and polyethylene glycol elicited by anti-SARS-CoV-2 mRNA vaccine, and effect of pre-existing anti-polyethylene glycol antibody in patients with hematological and autoimmune diseases., Heliyon, 10, 10, e31489, 2024. (Summary) The effects of vaccination are modified by hematological and autoimmune diseases and/or treatment. Anti-SARS-CoV-2 mRNA vaccine contains polyethylene glycol (PEG), it is largely unknown whether PEG influences the effects of vaccination or induces a humoral response. This study examined whether anti-PEG antibodies before vaccination (pre-existing) influenced the acquisition of SARS-CoV-2 antibodies and evaluated the relationship between the development of anti-SARS-CoV-2 antibodies and anti-PEG antibodies after SARS-CoV-2 vaccination in hematological and autoimmune diseases. Anti-SARS-CoV-2 antibody IgG, anti-PEG IgG, and IgM titers were evaluated in patients with hematological and autoimmune diseases after the second dose of BNT162B2. Anti-PEG IgG and IgM titers were also measured before vaccination to examine changes after vaccination and the relationship with vaccine efficacy. In patients with hematological (n = 182) and autoimmune diseases (n = 96), anti-SARS-CoV-2 and anti-PEG antibody titers were evaluated after a median of 33 days from 2nd vaccination. The median anti-SARS-CoV-2 antibody titers were 1901 AU/mL and 3832 AU/mL in patients with hematological and autoimmune disease, respectively. Multiple regression analysis showed that age and days from 2nd vaccination were negatively associated with anti-SARS-CoV-2 antibody titers. Anti-CD20 antibody treatment was negatively correlated with anti-SARS-CoV-2 antibody titers in hematological disease, and C-reactive protein (CRP) was positively correlated with anti-SARS-CoV-2 antibody titers in autoimmune disease. Baseline anti-PEG antibody titers were significantly higher in patients with autoimmune disease but were not correlated with anti-SARS-CoV-2 antibody titers. Patients with increased anti-PEG IgG acquired higher anti-SARS-CoV-2 antibody titers in patients with autoimmune disease. Anti-SARS-CoV-2 antibody acquisition was suboptimal in patients with hematological disease, but both anti-SARS-CoV-2 antibody and anti-PEG IgG were acquired in patients with autoimmune disease, reflecting robust humoral immune response. Pre-existing anti-PEG antibody titers did not affect anti-SARS-CoV-2 antibody acquisition. (Tokushima University Institutional Repository) ● Metadata: 2012299 (Link to Publication Site) ● Publication site (DOI): 10.1016/j.heliyon.2024.e31489 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 38813140 ● Summary page in Scopus @ Elsevier: 2-s2.0-85193252659 (Tokushima University Institutional Repository: 2012299, DOI: 10.1016/j.heliyon.2024.e31489, PubMed: 38813140, Elsevier: Scopus)
5.	Taiki Hori, Ken-ichi Aihara, Koki Ishida, Kaori Inaba, Keisuke Inaba, Yousuke Kaneko, Keisuke Kawahito, Shoki Bekku, Minae Hosoki, Kensuke Mori, Kanako Itami, Masayo Katsuse, Yoshimi Hanaoka, Teruyoshi Kageji, Hideyuki Uraoka and Shingen Nakamura : Usefulness of Palliative Prognostic Index, Objective Prognostic Score, and Neutrophil-Lymphocyte Ratio/Albumin Ratio As Prognostic Indicators for Patients Without Cancer Receiving Home-Visit Palliative Care: A Pilot Study at a Community General Hospital., Palliative Medicine Reports, 5, 1, 142-149, 2024. (Summary) PPI, OPS, and NLR/Alb were useful in predicting the survival period and short-term prognosis within 21 days for patients without cancer who received home-visit palliative care. (Tokushima University Institutional Repository) ● Metadata: 2011957 (Link to Publication Site) ● Publication site (DOI): 10.1089/pmr.2023.0096 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 38596695 ● Summary page in Scopus @ Elsevier: 2-s2.0-85190614948 (Tokushima University Institutional Repository: 2011957, DOI: 10.1089/pmr.2023.0096, PubMed: 38596695, Elsevier: Scopus)
6.	Taiki Hori, Shingen Nakamura and Ken-ichi Aihara : Clinical Significance of Phase Angle and Extracellular Water-to-Total Body Water Ratio Measured by Bioelectrical Impedance Analysis, Journal of Leukemia, 12, 2, 368, 2024. (Summary) Bioelectrical Impedance Analysis (BIA) is a simple and noninvasive method used to estimate body composition, Phase Angle (PhA), and Extracellular Water-to-Total Body Water Ratio (ECW/TBW). PhA serves as an indicator of cell mass, cellular integrity, and healthiness of the cell membranes. ECW/TBW is an indicator of cellular volume valance. Both metrics can be used to comprehensively assess the structural integrity of the body, including nutritional status and inflammation. Evidence suggests a close correlation of these parameters with prognosis and disease progression in non-cancer patients such as diabetes mellitus and in cancer patients, including those with hematological malignancies. BIA may be a valuable tool for assessing the current body status as well as for future predictions across different disease domains. (Keyword) Bioelectrical impedance analysis / Phase angle / Extracellular water-to-total body water ratio (Tokushima University Institutional Repository) ● Metadata: 2012298 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1050022708917615104 (Tokushima University Institutional Repository: 2012298, CiNii: 1050022708917615104)
7.	Minae Hosoki, Taiki Hori, KANEKO Yohsuke, Kensuke Mori, Saya Yasui, Seijiro Tsuji, Hiroki Yamagami, Saki Kawata, Tomoyo Hara, Shiho Masuda, Yukari Mitsui, Kiyoe Kurahashi, Takeshi Harada, Shingen Nakamura, Toshiki Otoda, Tomoyuki Yuasa, Akio Kuroda, Itsuro Endo, Munehide Matsuhisa and Ken-ichi Aihara : Causes of In-Hospital Death and Pharmaceutical Associations with Age of Death during a 10-Year Period (2011-2020) in Individuals with and without Diabetes at a Japanese Community General Hospital., Journal of Clinical Medicine, 13, 5, 1283, 2024. (Summary) Since diabetes and its complications have been thought to exaggerate cardiorenal disease, resulting in a short lifespan, we investigated causes of death and lifespans in individuals with and without diabetes at a Japanese community general hospital during the period from 2011 to 2020. Causes of death and age of death in individuals with and those without diabetes were compared, and associations between medications used and age of death were statistically analyzed. A total of 2326 deaths were recorded during the 10-year period. There was no significant difference between the mean ages of death in individuals with and those without diabetes. Diabetic individuals had higher rates of hepato-pancreatic cancer and cardio-renal failure as causes of death. The prescription rates of antihypertensives, antiplatelets, and statins in diabetic individuals were larger than those in non-diabetic individuals. Furthermore, the use of sulfonyl urea or glinides and insulin was independently and inversely associated with the age of death. In conclusion, individuals with diabetes were treated with comprehensive pharmaceutical interventions and had life spans comparable to those of individuals without diabetes. This study's discovery of an inverse relationship between the use of insulin secretagogues or insulin and the age of death suggests that the prevention of life-threatening hypoglycemia is crucial for individuals with diabetes. (Tokushima University Institutional Repository) ● Metadata: 2011959 (Link to Publication Site) ● Publication site (DOI): 10.3390/jcm13051283 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 38592103 ● Summary page in Scopus @ Elsevier: 2-s2.0-85187472209 (Tokushima University Institutional Repository: 2011959, DOI: 10.3390/jcm13051283, PubMed: 38592103, Elsevier: Scopus)
8.	Taiki Hori, Shingen Nakamura and Ken-ichi Aihara : Phase Angle and Extracellular Water-to-Total Body Water Ratio Measured by Bioelectrical Impedance Analysis, J Leuk. 12:368,2024., 2024.
9.	Taiki Hori, Shingen Nakamura, Hiroki Yamagami, Saya Yasui, Minae Hosoki, Tomoyo Hara, Yukari Mitsui, Shiho Masuda, Kiyoe Kurahashi, Sumiko Yoshida, Takeshi Harada, Akio Kuroda, Toshiki Otoda, Tomoyuki Yuasa, Itsuro Endo, Munehide Matsuhisa, Masahiro Abe and Ken-ichi Aihara : Phase angle and extracellular water-to-total body water ratio estimated by bioelectrical impedance analysis are associated with levels of hemoglobin and hematocrit in patients with diabetes., Heliyon, 9, 4, 2023. (Summary) PhA and ECW/TBW but not SMI were associated with levels of Hgb and Hct in patients with diabetes. Therefore, aberrant values of PhA and ECW/TBW suggest a risk of anemia in diabetic patients. (Tokushima University Institutional Repository) ● Metadata: 2011013 (Link to Publication Site) ● Publication site (DOI): 10.1016/j.heliyon.2023.e14724 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 37057050 ● Summary page in Scopus @ Elsevier: 2-s2.0-85150788405 (Tokushima University Institutional Repository: 2011013, DOI: 10.1016/j.heliyon.2023.e14724, PubMed: 37057050, Elsevier: Scopus)
10.	Taiki Hori, Saya Yasui, Minae Hosoki, Hiroki Yamagami, Toshiki Otoda, Tomoyuki Yuasa, Kenichi Aihara, Makoto Takishita, Akihiko Yokohama, Mitusharu Ueda, Masahiro Abe and Shingen Nakamura : Systemic amyloidosis associated with non-IgM type paraprotein with lymphoplasmacytic lymphoma, International Journal of Myeloma, 13, 2, 7-12, 2023. (Tokushima University Institutional Repository) ● Metadata: 2011339 (Link to Publication Site) ● Publication site (DOI): 10.57352/ijm.13.2_7 (Link to Search Site for Scientific Articles) ● Search Scopus @ Elsevier (DOI): 10.57352/ijm.13.2_7 (Tokushima University Institutional Repository: 2011339, DOI: 10.57352/ijm.13.2_7)
11.	Shingen Nakamura, Motoki Sugasaki, Masayoshi Souri, Hirohito Akazawa, Maiko Sogawa, Taiki Hori, Hiroki Yamagami, Makoto Takishita, Ken-ichi Aihara, Masahiro Abe, Atsushi Yasumoto, Eriko Morishita and Akitada Ichinose : Autoimmune Acquired Factor XIII/13 Deficiency after SARS-CoV-2 mRNA Vaccination., Thrombosis and Haemostasis, 2022. (Tokushima University Institutional Repository) ● Metadata: 2011100 (Link to Publication Site) ● Publication site (DOI): 10.1055/a-1863-7265 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 35636450 ● Search Scopus @ Elsevier (PMID): 35636450 ● Search Scopus @ Elsevier (DOI): 10.1055/a-1863-7265 (Tokushima University Institutional Repository: 2011100, DOI: 10.1055/a-1863-7265, PubMed: 35636450)
12.	Yousuke Kaneko, Motoki Sugasaki, Naoto Okada, Mako Niimi, Saya Yasui, Taiki Hori, Ken-ichi Aihara, Makoto Takishita, Masahiro Abe and Shingen Nakamura : Artifactual prolongation of the activated partial thromboplastin time by amikacin or gentamicin with ellagic acid, but not silica activated reagent., International Journal of Laboratory Hematology, 44, 2, e72-e75, 2021. (Keyword) Amikacin / Anti-Bacterial Agents / Ellagic Acid / Gentamicins / Humans / Indicators and Reagents / Partial Thromboplastin Time / Silicon Dioxide (Tokushima University Institutional Repository) ● Metadata: 2011123 (Link to Publication Site) ● Publication site (DOI): 10.1111/ijlh.13718 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 34585530 ● Summary page in Scopus @ Elsevier: 2-s2.0-85115829007 (Tokushima University Institutional Repository: 2011123, DOI: 10.1111/ijlh.13718, PubMed: 34585530, Elsevier: Scopus)

Proceeding of International Conference:

1.	Junpei Murai, Shingen Nakamura, Yasunobu Okamoto, Taiki Hori, Tomoyuki Yuasa, Ken-ichi Aihara, Makoto Takishita, Takeshi Harada and Ken-ichi Matsuoka : Factors Associated With Elevation Of Alkaline Phosphatase After First-Line Chemotherapy in Newly Diagnosed Multiple Myeloma By Japan Medical Data Center Claim Database., The 66th ASH Annual Meeting and Exposition in San Diego, California, San Diego, Dec. 2024. (Link to Publication Site) ● Publication site (DOI): 10.1182/blood-2024-202277 (Link to Search Site for Scientific Articles) ● Search Scopus @ Elsevier (DOI): 10.1182/blood-2024-202277 (DOI: 10.1182/blood-2024-202277)
2.	Minae Hosoki, Hiroki Yamagami, Taiki Hori, Saya Yasui, Tomoyo Hara, Kiyoe Kurahashi, Sumiko Yoshida, Shingen Nakamura, Toshiki Otoda, Tomoyuki Yuasa, Itsuro Endo, Masahiro Abe and Ken-ichi Aihara : Pharmaceutical Influences on In-hospital Death in Patients with and Those without Diabetes at a Japanese General Hospital, The 29th Scientific Meeting of the International Society of Hypertension, Oct. 2022.
3.	Yamagami Hiroki, Yasui Saya, Hosoki Minae, Taiki Hori, Tomoyo Hara, Kurahashi Kiyoe, Yoshida Sumiko, Nakamura Shingen, Otoda Toshiki, Yuasa Tomoyuki, Endo Itsuro, Abe Masahiro and Masahiro Abe : Skin autofluorescence is associated with tubular injury represented by urinary excretion of liver-type fatty acid-binding protein in patients with diabetes., The American Diabetes Association's 82nd Scientific Sessions, New Orleans, Louisiana., Jun. 2022.
4.	Ken-ichi Aihara, Yamagami Hiroki, Yasui Saya, Hosoki Minae, Taiki Hori, Shingen Nakamura, Toshiki Otoda and Tomoyuki Yuasa : Clinical Significance of Dehydroepiandrosterone Sulfate in Carotid Atherosclerosis and Nonalcoholic Fatty Liver Disease, ESMED Congress 2021, Nov. 2021.

Proceeding of Domestic Conference:

1.	金子遥祐, 河田沙紀, 森建介, 細木美苗, Taiki Hori, 宮髙紘輔, 辻誠士郎, Tomoyo Hara, Hiroki Yamagami, Toshiki Otoda, Tomoyuki Yuasa, Yutaka Kawano, Shingen Nakamura, Akio Kuroda, Itsuro Endo, Munehide Matsuhisa, Ken-ichi Matsuoka and Ken-ichi Aihara : 代謝異常関連脂肪性肝疾患と赤血球Mean Corpuscular Volume の連関解析, 第68回日本糖尿病学会年次学術集会, May 2025.
2.	Ken-ichi Aihara, Tomoyo Hara, Hiroki Yamagami, 金子遥祐, 宮髙紘輔, Taiki Hori, Tomoyuki Yuasa, Hiroyasu Mori, Akio Kuroda, Shingen Nakamura, Itsuro Endo, Ken-ichi Matsuoka and Munehide Matsuhisa : 生体電気インピーダンス法による位相角の糖尿病関連腎臓病における臨床的意義, 第68回日本糖尿病学会年次学術集会, May 2025.
3.	Ken-ichi Aihara, Tomoyo Hara, Hiroki Yamagami, Yohsuke Kaneko, Kosuke Miyataka, Taiki Hori, Tomoyuki Yuasa, Hiroyasu Mori, Akio Kuroda, Shingen Nakamura, Itsuro Endo, Ken-ichi Matsuoka and Munehide Matsuhisa : 生体電気インピーダンス法による位相角の糖尿病関連腎臓病における臨床的意義, 第68回日本糖尿病学会年次学術集会, May 2025.
4.	Ken-ichi Aihara, Tomoyuki Yuasa, Shingen Nakamura, 村井純平, 岡本恵暢, KANEKO Yohsuke, 森建介, 細木美苗, Taiki Hori, 河田沙紀, 辻誠士郎, 安井沙耶, Hiroki Yamagami, Tomoyo Hara, Toshiki Otoda and Itsuro Endo : 来院時心肺停止・死亡転帰患者の臨床背景における糖尿病有無の影響に関する検討, 第24回日本内分泌学会四国支部学術集会, Sep. 2024.
5.	KANEKO Yohsuke, Kensuke Mori, Minae Hosoki, Taiki Hori, 辻誠士郎, Toshiki Otoda, Tomoyuki Yuasa, Shingen Nakamura and Ken-ichi Aihara : 2型糖尿病患者の年間HbA1c変動と肝線維化指標の連関解析, 第67回日本糖尿病学会年次学術集会, May 2024.
6.	金子遥祐, 河田沙紀, 森建介, 細木美苗, Taiki Hori, 辻誠士郎, Toshiki Otoda, Tomoyuki Yuasa, Shingen Nakamura and Ken-ichi Aihara : 赤血球のmean corpuscular volumeと代謝異常関連脂肪肝疾患の連関解析, Folia endocrinologica Japonica, 100, 1, 339, May 2024.
7.	Taiki Hori, 石田晃基, Kaori Inaba, Keisuke Inaba, KANEKO Yohsuke, Minae Hosoki, Kensuke Mori, Ken-ichi Aihara and Shingen Nakamura : 内科救急疾患患者におけるRespiratory adjusted shock indexの有用性, 第121回日本内科学会総会・講演会, Apr. 2024.
8.	KANEKO Yohsuke, Kensuke Mori, Taiki Hori, Minae Hosoki, 辻誠士郎, 河田沙紀, Toshiki Otoda, Tomoyuki Yuasa, Shingen Nakamura and Ken-ichi Aihara : 代謝異常関連脂肪肝疾患におけるmean corpuscular volumeの意義, 第121回日本内科学会総会・講演会, Apr. 2024.
9.	Taiki Hori, Ken-ichi Aihara, 石田晃基, Kaori Inaba, Keisuke Inaba, Yohsuke Kaneko, Keisuke Kawahito, 別宮彰起, Minae Hosoki, Kensuke Mori, ITAMI Kanako, 勝瀬昌代, 花岡賀美, Teruyoshi Kageji, 浦岡秀行 and Shingen Nakamura : 非がん在宅療養患者における予後予測指標の有用性についての検討, 第268回徳島医学会学術集会, Mar. 2024.
10.	Taiki Hori, 石田晃基, 稲葉香織, 稲葉圭佑, 金子遥祐, 川人圭祐, 細木美苗, 森建介, Ken-ichi Aihara and Shingen Nakamura : 内科救急疾患患者におけるRespiratory adjusted shock indexの有用性, 日本内科学会雑誌, 113, 195, Feb. 2024. (Keyword) *救急疾患(予後) 脈拍呼吸数ヒト男女
11.	Taiki Hori, 金子遥祐, 細木美苗, 森建介, 村井純平, Toshiki Otoda, Tomoyuki Yuasa, Ken-ichi Aihara, 滝下誠 and Shingen Nakamura : 生活習慣病患者におけるヘモグロビン値と関連因子の検討, 日本血液学会学術集会, 689, Oct. 2023. (Keyword) Hemoglobins 生活習慣病(診断,予後) ヒト中年(45∼64) 高齢者(65∼79) 男女
12.	Taiki Hori, 石田晃基, 稲葉香織, 稲葉圭佑, 金子遙祐, 川人圭祐, 細木美苗, 森建介, 影治照喜, 浦岡秀行, Ken-ichi Aihara and Shingen Nakamura : 非がん在宅療養患者の予後予測についての検討, Palliative Care Research, 18, Suppl._Chugoku-Shikoku, S646, Sep. 2023. (Keyword) Albumins 好中球白血球計数ターミナルケア予後リスク評価リンパ球計数在宅死 *臨床意思決定ルールヒト
13.	Shingen Nakamura, Taiki Hori, 谷彰浩, 細木美苗, 安井沙耶, 宮田好裕, Hiroki Yamagami, 滝下誠 and Ken-ichi Aihara : 新型コロナワクチン接種後にvaccine-induced immune thrombotic thrombocytopeniaを疑われた症例, Japanese Journal of Geriatrics, 59, 4, 594, Oct. 2022.
14.	細木美苗, Hiroki Yamagami, 安井沙耶, Taiki Hori, Shingen Nakamura, Toshiki Otoda, Tomoyuki Yuasa and Ken-ichi Aihara : 当院10年間における死亡患者の年齢・死因および併存合併症における糖尿病と治療薬剤の影響, 第22回日本糖尿病インフォマティクス学会年次学術集会, Aug. 2022.
15.	Taiki Hori, Shingen Nakamura, Akihiro Tani, Minae Hosoki, Saya Yasui, Yoshihiro Miyata, Hiroki Yamagami, 辻誠士郎, Ken-ichi Aihara and 滝下誠 : 初発時にヘルペスウイルス属の再活性化と中枢浸潤を伴い急速に悪化した成人T細胞白血病リンパ腫の1例, 第126回日本内科学会四国地方会, Jun. 2022.
16.	Shingen Nakamura, Taiki Hori, Minae Hosoki, Saya Yasui, Hiroki Yamagami, 赤澤啓人, 滝下誠 and Ken-ichi Aihara : FXIII/13, 第126回日本内科学会四国地方会, Jun. 2022.
17.	Shingen Nakamura, Taiki Hori, Minae Hosoki, Saya Yasui, Hiroki Yamagami, 赤澤啓人, 滝下誠 and Ken-ichi Aihara : 新型コロナワクチン接種後に発覚した自己免疫性出血病FXIII/13, 第126回日本内科学会四国地方会, Jun. 2022.
18.	本田壮一, Shingen Nakamura, 高橋啓輝, Taiki Hori and Masahiro Abe : 地域での造血腫瘍の診療を考える, 第126回日本内科学会四国地方会, Jun. 2022.
19.	Shingen Nakamura, Taiki Hori, Minae Hosoki, Saya Yasui, Hiroki Yamagami, 滝下誠, 答島章公 and Ken-ichi Aihara : 血液疾患，自己免疫疾患における新型コロナワクチン接種後の抗体獲得能の検討, 第96回日本感染症学会総会, May 2022.
20.	Shingen Nakamura, Taiki Hori, Masafumi Nakamura, Ryohei Sumitani, Masahiro Oura, Kimiko Sogabe, Tomoko Maruhashi, 高橋真美子, Shiroh Fujii, Hirokazu Miki, Takeshi Harada and Masahiro Abe : Humoral response of the mRNA vaccine against SARS-CoV-2 in patients with plasma cell dyscrasia, The 47th annual meeting of Japanese Society of Myeloma, May 2022.
21.	Shingen Nakamura, Taiki Hori, 中村昌史, Ryohei Sumitani, Masahiro Oura, Kimiko Sogabe, 丸橋朋子, 髙橋真美子, Shiroh Fujii, Hirokazu Miki, Takeshi Harada and Masahiro Abe : 形質細胞疾患における新型コロナワクチンの有効性, 第47回日本骨髄腫学会学術集会, May 2022.
22.	山上紘規, 細木美苗, Taiki Hori, 安井沙耶, Shingen Nakamura, Tatsuya Taniguchi, Toshiki Otoda, Tomoyuki Yuasa, Takeshi Soeki and Ken-ichi Aihara : Skin Autofluorescenceの糖尿病性腎臓病における臨床的意義の解析, 第65回日本糖尿病学会年次学術集会, May 2022.
23.	細木美苗, 山上紘規, 安井沙耶, Taiki Hori, Shingen Nakamura, Toshiki Otoda, Tomoyuki Yuasa and Ken-ichi Aihara : 当院10年間における死亡患者の年齢・死因および併存合併症における糖尿病と治療薬剤の影響, 第65回日本糖尿病学会年次学術集会, May 2022.
24.	Shingen Nakamura, Taiki Hori, 中村昌史, Ryohei Sumitani, Masahiro Oura, Kimiko Sogabe, 丸橋朋子, 高橋真美子, Shiroh Fujii, Hirokazu Miki, Takeshi Harada, Ken-ichi Aihara and Masahiro Abe : 形質細胞異常症患者におけるSARS-CoV-2に対するmRNAワクチンの液性免疫応答の評価(Humoral response of the mRNA vaccine against SARS-CoV-2 in patients with plasma cell dyscrasia), International Journal of Myeloma, 12, 3, 199, May 2022. (Keyword) 予防接種単クローン性免疫グロブリン血症-良性(免疫学) 液性免疫アミロイドーシス-免疫グロブリン軽鎖(免疫学) *COVID-19ワクチン(治療的利用,薬理学)
25.	Hiroki Yamagami, Shingen Nakamura, Akihiro Tani, Minae Hosoki, Saya Yasui, Yoshihiro Miyata, Taiki Hori, 答島章公, Ken-ichi Aihara and 滝下誠 : 自己免疫疾患における新型コロナワクチンによる抗体獲得能の検討, 第119回日本内科学会総会, Apr. 2022.
26.	Taiki Hori, Shingen Nakamura, Akihiro Tani, Minae Hosoki, Saya Yasui, Yoshihiro Miyata, Hiroki Yamagami, 答島章公, Ken-ichi Aihara and 滝下誠 : 血液疾患患者における新型コロナウイルスワクチン接種による抗体獲得能の検討, 第119回日本内科学会総会, Apr. 2022.
27.	Shingen Nakamura, Taiki Hori, 細木美苗, 安井沙耶, Hiroki Yamagami, 答島章公, 滝下誠 and Ken-ichi Aihara : 血液疾患，自己免疫疾患における新型コロナワクチン接種後の抗体獲得能の検討, Kansenshōgaku Zasshi, 96, 130, Mar. 2022. (Keyword) 血液疾患(薬物療法) ウイルス抗体自己免疫疾患(薬物療法) 予防接種 *COVID-19ワクチン(治療的利用) ヒト中年(45∼64) 高齢者(65∼79) 高齢者(80∼) 男女
28.	Shingen Nakamura, Taiki Hori, 細木美苗, 安井沙耶, 山上紘規, 滝下誠 and Ken-ichi Aihara : 新型コロナワクチン接種後にvaccine-induced immune thrombotic thrombocytopeniaを疑われた症例., 第33回日本老年病学会四国地方会, 2022年1月23日(Web開催), Feb. 2022.
29.	Hiroki Yamagami, Shingen Nakamura, 細木美苗, Taiki Hori, 安井沙耶, Ken-ichi Aihara, 答島章公 and 滝下誠 : 自己免疫疾患における新型コロナワクチンによる抗体獲得能の検討, The Journal of the Japanese Society of Internal Medicine, 111, Suppl., 218, Feb. 2022. (Keyword) Azathioprine(治療的利用) Methotrexate(治療的利用) Steroids(治療的利用) 関節炎-乾癬性(薬物療法) 関節リウマチ(薬物療法) ウイルス抗体予防接種 Janus Kinase Inhibitors(治療的利用) COVID-19(予防,薬物療法) *COVID-19ワクチン(治療的利用) ヒト中年(45∼64) 高齢者(65∼79) 高齢者(80∼) 男女
30.	Taiki Hori, Shingen Nakamura, 谷彰浩, 細木美苗, 安井沙耶, 宮田好裕, Hiroki Yamagami, 答島章公, Ken-ichi Aihara and 滝下誠 : 血液疾患患者における新型コロナウイルスワクチン接種による抗体獲得能の検討, The Journal of the Japanese Society of Internal Medicine, 111, Suppl., 220, Feb. 2022. (Keyword) コロナウイルス感染症(予防,薬物療法) ウイルスワクチン(治療的利用) 血液疾患ウイルス抗体肺炎-ウイルス性(予防,薬物療法) 予防接種 COVID-19(予防,薬物療法) *COVID-19ワクチン(治療的利用) ヒト成人(19∼44) 中年(45∼64) 高齢者(65∼79) 高齢者(80∼) 男女
31.	Taiki Hori, Shingen Nakamura, Akihiro Tani, Minae Hosoki, Saya Yasui, Hiroki Yamagami, Ken-ichi Aihara, Yuko Miyagami, Takeshi Oya and 滝下誠 : T1, 第125回日本内科学会四国地方会, Dec. 2021.
32.	Taiki Hori, Shingen Nakamura, Minae Hosoki, Saya Yasui, Hiroki Yamagami, 滝下誠 and Ken-ichi Aihara : 血管中心性に浸潤し急速な経過で死に至った末梢性T細胞リンパ腫の1剖検例, 第125回日本内科学会四国地方会, Dec. 2021.
33.	細木美苗, 山上紘規, 安井沙耶, Taiki Hori, Shingen Nakamura, Toshiki Otoda, Tomoyuki Yuasa and Ken-ichi Aihara : 当院死亡患者の年齢・死因および併存合併症における糖尿病の影響, 第59回日本糖尿病学会中国四国地方会, Oct. 2021.
34.	細木美苗, 山上紘規, 安井沙耶, Taiki Hori, Shingen Nakamura, Toshiki Otoda, Tomoyuki Yuasa and Ken-ichi Aihara : 糖尿病の有無からみた当院死亡患者の年齢・死因および併存合併症に関する検討, 第21回日本内分泌学会四国支部学術集会, Sep. 2021.
35.	Yohsuke Kaneko, Saya Yasui, Hiroki Yamagami, Taiki Hori, Shingen Nakamura, Tatsuya Taniguchi, Toshiki Otoda, Tomoyuki Yuasa, Takeshi Soeki and Ken-ichi Aihara : 糖尿病患者における歩行速度規定臨床因子の解析, 第64回日本糖尿病学会年次学術集会, May 2021.
36.	Ken-ichi Aihara, Taiki Hori, Hiroki Yamagami, Saya Yasui, Yohsuke Kaneko, Shingen Nakamura, Tatsuya Taniguchi, Toshiki Otoda, Tomoyuki Yuasa, Takeshi Soeki and Masahiro Abe : 生体電気インピーダンス法による細胞外水分比および位相角と糖尿病患者における血中HbおよびHtレベルの連関解析, 第64回日本糖尿病学会年次学術集会, May 2021.
37.	Hiroki Yamagami, Saya Yasui, Yohsuke Kaneko, Taiki Hori, Shingen Nakamura, Tatsuya Taniguchi, Toshiki Otoda, Tomoyuki Yuasa, Takeshi Soeki and Ken-ichi Aihara : 糖尿病患者におけるDehydroepiandrosterone sulfate (DHEAS)の糖尿病性腎臓病進展および高血圧症罹患における意義, 第64回日本糖尿病学会年次学術集会, May 2021.
38.	Saya Yasui, Hiroki Yamagami, Yohsuke Kaneko, Taiki Hori, Shingen Nakamura, Tatsuya Taniguchi, Toshiki Otoda, Tomoyuki Yuasa, Takeshi Soeki and Ken-ichi Aihara : 糖尿病患者における非アルコール性脂肪肝疾患および骨格筋異常症におけるDehydroepiandrosterone sulfate (DHEAS)の意義, 第64回日本糖尿病学会年次学術集会, May 2021.
39.	Taiki Hori, Shingen Nakamura, 金子遥祐, 安井沙耶, Hiroki Yamagami, Ken-ichi Aihara and 滝下誠 : 1, 第124回日本内科学会四国地方会, May 2021.
40.	Taiki Hori, Shingen Nakamura, Minae Hosoki, Saya Yasui, Hiroki Yamagami, 滝下誠 and Ken-ichi Aihara : 腫大リンパ節に著明なアミロイド沈着を認めたリンパ形質細胞性リンパ腫の1例, 第124回日本内科学会四国地方会, May 2021.
41.	安井沙耶, 山上紘規, 金子遥祐, Taiki Hori, Shingen Nakamura, 谷口達哉, 乙田敏城, 湯浅智之, 添木武 and 粟飯原賢一 : 糖尿病患者における非アルコール性脂肪肝疾患および骨格筋異常症におけるDehydroepiandrosterone sulfate(DHEAS)の意義, Journal of the The Japan Diabetes Society, 64, Suppl.1, I-11-3, May 2021. (Keyword) diabetes / Dehydroepiandrosterone Sulfate / 骨格筋 / 筋肉減少症 / 肝疾患 / 非アルコール性脂肪性 / ヒト / male / female
42.	金子遥祐, Tomoyuki Yuasa, Takeshi Soeki, Toshiki Otoda, Tatsuya Taniguchi, Ken-ichi Aihara, 安井沙耶, Taiki Hori, 山上紘規 and Shingen Nakamura : 糖尿病患者における歩行速度規定臨床因子の解析, Journal of the The Japan Diabetes Society, 64, Suppl.1, III-133-4, May 2021.
43.	山上紘規, 安井沙耶, 金子遥祐, Taiki Hori, Shingen Nakamura, Tatsuya Taniguchi, Toshiki Otoda, Tomoyuki Yuasa, Takeshi Soeki and Ken-ichi Aihara : 糖尿病患者におけるDehydroepiandrosterone sulfate(DHEAS)の糖尿病性腎臓病進展および高血圧症罹患における意義, Journal of the The Japan Diabetes Society, 64, Suppl.1, P-35-6, May 2021.
44.	Taiki Hori, Hiroki Yamagami, Saya Yasui, Yohsuke Kaneko, Shingen Nakamura, Tatsuya Taniguchi, Toshiki Otoda, Tomoyuki Yuasa, Takeshi Soeki, Masahiro Abe and Ken-ichi Aihara : 生体電気インピーダンス法による細胞外水分比および位相角は糖尿病患者の血中HbおよびHtレベルを規定する, 第94回日本内分泌学会学術総会, Apr. 2021.
45.	Hiroki Yamagami, Saya Yasui, Yohsuke Kaneko, Taiki Hori, Shingen Nakamura, Tatsuya Taniguchi, Toshiki Otoda, Tomoyuki Yuasa, Takeshi Soeki and Ken-ichi Aihara : Dehydroepiandrosterone sulfate (DHEAS)高値は糖尿病性腎臓病進展および高血圧症罹患のリスクとなる, 第94回日本内分泌学会学術総会, Apr. 2021.
46.	Yohsuke Kaneko, Saya Yasui, Hiroki Yamagami, Taiki Hori, Shingen Nakamura, Tatsuya Taniguchi, Toshiki Otoda, Tomoyuki Yuasa, Takeshi Soeki and Ken-ichi Aihara : 生活習慣病患者の歩行速度は骨格筋量よりも筋力が規定する, 第94回日本内分泌学会学術総会, Apr. 2021.
47.	金子遥祐, 安井沙耶, 山上紘規, Taiki Hori, Shingen Nakamura, Tatsuya Taniguchi, Toshiki Otoda, Tomoyuki Yuasa, Takeshi Soeki and Ken-ichi Aihara : 生活習慣病患者の歩行速度は骨格筋量よりも筋力が規定する, Folia endocrinologica Japonica, 97, 1, 366, Apr. 2021. (Keyword) 筋骨格系生理学的現象骨格筋身体組成筋力生活習慣病(診断) 歩行速度 *筋量ヒト男女
48.	山上紘規, 金子遥祐, 安井沙耶, Taiki Hori, Shingen Nakamura, Tatsuya Taniguchi, Toshiki Otoda, Tomoyuki Yuasa, Takeshi Soeki and Ken-ichi Aihara : Dehydroepiandrosterone sulfate(DHEAS)高値は糖尿病性腎臓病進展および高血圧症罹患のリスクとなる, Folia endocrinologica Japonica, 97, 1, 340, Apr. 2021. (Keyword) 高血圧(病因,診断) 糖尿病性腎症(病因,診断) *Dehydroepiandrosterone Sulfate(血液) ヒト男女
49.	安井沙耶, 山上紘規, 金子遥祐, Taiki Hori, Shingen Nakamura, Tatsuya Taniguchi, Toshiki Otoda, Tomoyuki Yuasa, Takeshi Soeki and Ken-ichi Aihara : Dehydroepiandrosterone sulfate(DHEAS)は生活習慣病患者における非アルコール性脂肪肝疾患およびダイナペニアの発症抑制因子である, Folia endocrinologica Japonica, 97, 1, 287, Apr. 2021. (Keyword) Dehydroepiandrosterone Sulfate(血液) 生活習慣病(診断,病因,合併症) *肝疾患-非アルコール性脂肪性(診断,病因,合併症) ヒト男女
50.	安井沙耶, 山上紘規, 金子遥祐, Taiki Hori, Shingen Nakamura, Tatsuya Taniguchi, Toshiki Otoda, Tomoyuki Yuasa, Takeshi Soeki and Ken-ichi Aihara : 当院生活習慣病患者における骨格筋量に影響を与える因子の検討, Folia endocrinologica Japonica, 96, 3, 822, Jan. 2021. (Keyword) 筋骨格系生理学的現象 / 骨格筋 / 身体組成 / 生活習慣病(診断) / 筋量 / ヒト / 中年(45~64) / 高齢者(65~79) / 男 / 女
51.	山上紘規, 安井沙耶, 金子遥祐, Taiki Hori, Shingen Nakamura, Tatsuya Taniguchi, Toshiki Otoda, Tomoyuki Yuasa, Takeshi Soeki and Ken-ichi Aihara : 当院生活習慣病患者における握力と歩行速度に影響を与える因子の検討, Folia endocrinologica Japonica, 96, 3, 822, Jan. 2021. (Keyword) aging / 握力 / 生活習慣病(診断) / 歩行速度 / 中年(45~64) / 高齢者(65~79) / male / female
52.	Yohsuke Kaneko, Shingen Nakamura, Minae Hosoki, Saya Yasui, Hiroki Yamagami, Taiki Hori, 滝下誠 and Ken-ichi Aihara : アミカシンによるAPTT偽延長を来したSerratia marcescens菌血症の1例, 第123回日本内科学会四国地方会, Nov. 2020.
53.	Kiyoe Kurahashi, 村井純平, Taiki Hori, Ryohei Sumitani, Takeshi Harada, Shingen Nakamura, Mai Kanai, Akiko Sakurai, Tomoyo Hara, 桝田志保, Sumiko Yoshida, Itsuro Endo, 松本俊夫, Masahiro Abe and Seiji Fukumoto : 高1,25(OH)2D血症による高Ca血症を来したホジキンリンパ腫の一例, The Annual Meeting of the Japanese Society for Bone and Mineral Research Program & Abstracts, 150, Oct. 2020. (Keyword) Calcitriol Dacarbazine(治療的利用) Doxorubicin(治療的利用) Hodgkin病(合併症,病理学,薬物療法) Vinblastine(治療的利用) *高カルシウム血症(病因,病理学,薬物療法) 免疫組織化学 Brentuximab Vedotin(治療的利用) ヒト高齢者(65~79) 男
54.	Masahiro Oura, Shingen Nakamura, Taiki Hori, Kimiko Sogabe, Takeshi Harada, Shiroh Fujii, Hirokazu Miki, Kumiko Kagawa, Tomoko Kobayashi, Takeshi Oya and Masahiro Abe : 結節性紅斑と悪性腫瘍関連血球貪食症候群を惹起した骨髄異形成症候群の1例, The Japanese Journal of Clinical Hematology, 61, 10, 1542, Oct. 2020. (Keyword) 骨髄異形成症候群(合併症) 紅斑-結節性(病因) *血球貪食性リンパ組織球症(病因) ヒト中年(45~64) 男
55.	中村昌史, Hirokazu Miki, Masahiro Oura, 川田知代, Taiki Hori, 村井純平, Ryohei Sumitani, Kimiko Sogabe, 高橋真美子, Takeshi Harada, Shiroh Fujii, Shingen Nakamura, Kumiko Kagawa, 菅崎幹樹, 徳永尚樹, Akishige Ikegame, 森下英理子 and Masahiro Abe : クロスミキシングテストの特徴的な所見が診断の契機となったプレカリクレイン欠乏症の1例, The Japanese Journal of Clinical Hematology, 61, 10, 1537-1538, Oct. 2020. (Keyword) Prekallikrein(欠損・欠乏) 血液凝固異常(診断) *血液凝固検査ヒト中年(45~64) 男
56.	Yohsuke Kaneko, Saya Yasui, Taiki Hori, Hiroki Yamagami, Toshiki Otoda, Tomoyuki Yuasa and Ken-ichi Aihara : インスリングラルギンU300とデュラグルチドの併用からインスリンデグルデク・リラグルチド配合製剤への変更後に著明な血糖コントロールの改善を見た1例, 第20回日本内分泌学会四国支部学術集会, Sep. 2020.
57.	Hiroki Yamagami, Saya Yasui, Yohsuke Kaneko, Taiki Hori, Shingen Nakamura, Tatsuya Taniguchi, Toshiki Otoda, Tomoyuki Yuasa, Takeshi Soeki and Ken-ichi Aihara : 当院生活習慣病患者における握力と歩行速度に影響を与える因子の検討, 第20回日本内分泌学会四国支部学術集会, Sep. 2020.
58.	Saya Yasui, Hiroki Yamagami, Yohsuke Kaneko, Taiki Hori, Shingen Nakamura, Tatsuya Taniguchi, Toshiki Otoda, Tomoyuki Yuasa, Takeshi Soeki and Ken-ichi Aihara : 当院生活習慣病患者における骨格筋量に影響を与える因子の検討, 第20回日本内分泌学会四国支部学術集会, Sep. 2020.
59.	村井純平, Taiki Hori, 川田知代, Ryohei Sumitani, 宇高憲吾, Takeshi Harada, Shiroh Fujii, Shingen Nakamura, Kumiko Kagawa, Masahiro Abe, Hirokazu Miki, 桝田志保, Itsuro Endo and Seiji Fukumoto : 高ビタミンD血症による高Ca血症を来したホジキンリンパ腫の一例, Shikoku Acta Medica, 76, 1-2, 124, Apr. 2020. (Keyword) Calcitriol(毒性・副作用,血液) / Hodgkin病(合併症,薬物療法) / Vitamin D(毒性・副作用,血液) / 高カルシウム血症(化学的誘発) / 腫瘍多剤併用療法 / ヒト / 高齢者(65~79) / 男

Designated Assistant Professor : Hori, Taiki

Research

Field of Study

Subject of Study

Book / Paper

Academic Paper (Judged Full Paper):

Proceeding of International Conference:

Proceeding of Domestic Conference: